Charles River Laboratories International, Inc.CRLNYSE
Loading
Year-over-year revenue growth rate
Percentile
P26
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -1.06% |
| Q3 2025 | -2.64% |
| Q2 2025 | 4.87% |
| Q1 2025 | -1.83% |
| Q4 2024 | -0.71% |
| Q3 2024 | -1.59% |
| Q2 2024 | 1.44% |
| Q1 2024 | -0.19% |
| Q4 2023 | -1.28% |
| Q3 2023 | -3.14% |
| Q3 2023 | 2.97% |
| Q2 2023 | -6.41% |
| Q4 2022 | 11.19% |
| Q3 2022 | 1.65% |
| Q2 2022 | 6.48% |
| Q1 2022 | 0.98% |
| Q4 2021 | 1.02% |
| Q3 2021 | -2.04% |
| Q2 2021 | 10.92% |
| Q1 2021 | 4.24% |
| Q4 2020 | 6.42% |
| Q3 2020 | 8.90% |
| Q2 2020 | -3.46% |
| Q1 2020 | 2.30% |
| Q4 2019 | 3.47% |
| Q3 2019 | 1.58% |
| Q2 2019 | 8.77% |
| Q1 2019 | 0.51% |
| Q4 2018 | 2.77% |
| Q3 2018 | -0.00% |
| Q2 2018 | 18.49% |
| Q1 2018 | 3.24% |
| Q4 2017 | 3.07% |
| Q3 2017 | -1.04% |
| Q3 2017 | 5.24% |
| Q2 2017 | -4.50% |
| Q4 2016 | 9.65% |
| Q3 2016 | -1.92% |
| Q2 2016 | 22.31% |
| Q1 2016 | 0.29% |